Bellus Health

Bellus Health: BELLUS Health- developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. BELLUS' lead product candidate, BLU-5937, is being developed for the treatment of chronic cough (Phase II announced July 2020) and chronic pruritus (Phase II planned to begin 1H20).

BELLUS' Phase II for chronic cough, the RELIEF study is a dose-escalation, placebo-controlled, and crossover design to assess the efficacy, safety, and tolerability of BLU-5937, a highly selective P2X3 antagonist, at four doses; 25, 50, 100 and 200 mg, administered orally, twice-daily (BID). Approximately 65 patients with refractory chronic cough are expected to be enrolled at twelve clinical sites in the United Kingdom and United States.
Based in...
North America
Clinical Stage
Phase l or ll
Disease Space
Dermatology, Respiratory
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Small Molecule
275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Company Participants at Hamptons CEO Roundtable 2019

  • Roberto Bellini, President & CEO

Top 10 Holders of BELLUS Health Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Avidity Partners Management LP 8.68 6,797,400 19.03 13F 3/31/21
Point72 Asset Management LP 7.94 6,220,058 17.42 Stakes 12/31/20
Point72 Asset Management LP (Old) 7.40 5,800,000 16.24 13F 3/31/21
RTW Investments LP 6.34 4,968,017 13.91 13F 3/31/21
Artal Group SA 6.06 4,750,000 13.30 13F 3/31/21
Invus Public Equities Advisors LLC 6.06 4,750,000 13.30 Stakes 1/11/21
OrbiMed Advisors LLC 5.05 3,954,800 11.07 13F 3/31/21
Polar Capital Holdings Plc 4.47 3,500,000 9.80 13F 3/31/21
Boxer Capital LLC 3.80 2,975,000 8.33 13F 3/31/21
Laurion Capital Management LP 3.72 2,913,619 8.16 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.